Navigation Links
Strategy to help doctors determine when to treat retinopathy of prematurity
Date:4/29/2010

NEW YORK (April 29, 2010) -- Scientists have shown that through eye examinations, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children.

These long-term results of the Early Treatment for Retinopathy of Prematurity (ETROP) study confirm that the visual benefit of early treatment for selected infants continues through six years of age. The research is published in the April 12 online issue of Archives of Ophthalmology and was supported by the National Eye Institute (NEI), part of the National Institutes of Health. The Edward S. Harkness Eye Institute at NewYork-Presbyterian Hospital/Columbia University Medical Center and NewYork-Presbyterian/Morgan Stanley Children's Hospital were among the 26 participating study sites.

"We showed that early treatment for high-risk premature babies can improve their vision. This research promises to transform the way babies with ROP are treated," says Dr. John Flynn, study principal investigator and the Anne S. Cohen Professor of Clinical Pediatric Ophthalmology at Columbia University College of Physicians and Surgeons and an ophthalmologist at NewYork-Presbyterian/Morgan Stanley Children's Hospital and professor of medicine at Weill Cornell Medical College.

"We showed there isn't a single treatment strategy that works for all infants with ROP, but rather that doctors need to determine whether the baby has a mild or severe form of the disease before proceeding with retinal surgery," adds study co-author Dr. Michael Chiang, associate professor of ophthalmology at Columbia University College of Physicians and Surgeons and an ophthalmologist at NewYork-Presbyterian Hospital/Columbia University Medical Center. "This can be determined with a simple bedside exam using an ophthalmoscope to look at blood vessels in the retina."

An estimated 15,000
'/>"/>

Contact: Belinda Mager
bem9048@nyp.org
212-305-5587
New York- Presbyterian Hospital/Columbia University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. A Nutty Super Bowl Snacks Strategy Helps Keep Diets in Play
2. Medical Breakthrough: Drug Free Strategy Shows Promise for Reversing or Halting Osteoporosis for Michigan Men and Women
3. Health Reform Needs Enforceable National Workforce Strategy
4. Research highlights need for national HIV strategy
5. Governor Rendell Proposes Budget With No Tax Increase, More Money for Public Schools, Strategy for Jobs, Plan to Address Future Deficits
6. SOKO Fitness & Spa Group Broadens Geographic Expansion Strategy
7. Keenan Chief Strategy Officer Selected to Join Editorial Board of Payers & Providers
8. Data Strategy Announces SurePath Services Offering for EMC Avamar
9. New strategy produces promising advance in cancer vaccines
10. New Cancer-Fighting Strategy Focuses On Signaling Molecules
11. Targeting leukemia cells gene addiction presents new strategy for treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... and they deal with the embarrassing skin blemishes ... or Roaccutane. Now, however, research from Tel Aviv ... eye infections such as conjunctivitis (pink eye) or ... TAU,s School of Public Health at the Sackler ... connection between acne and eye infections, but there ...
(Date:5/23/2012)... PITTSBURGH, May 23 In one of the most ... laparoscopic surgery for prostate cancer, researchers at UPMC found ... than standard open surgery, despite little scientific evidence of ... are available online and will appear in the July ... In one of the first studies based on actual ...
(Date:5/23/2012)... Blame it on your genes? Researchers from The Miriam ... variations in certain "obesity genes" tend to eat more meals ... the same types of high fat, sugary foods. , Their ... Nutrition and appearing in the June issue, reveals certain ... been previously linked to obesity may play a role ...
(Date:5/23/2012)... UK (May 23, 2012) The British Association ... the best methods to treat substance abuse and ... published by SAGE. A panel of experts has ... a detailed review of the evidence to help ... BAP guidelines target treatment of substance abuse, harmful ...
(Date:5/23/2012)... Karlstad University in Sweden shows that phthalates from PVC ... are substances suspected to cause asthma and allergies, as ... shows that children can ingest these softening agents with ... , Phthalates are a group of chemical compounds that ... common consumer goods such as toys, cleaning solvents, packaging, ...
Breaking Medicine News(10 mins):Health News:Common acne medication doubles risk of eye infection 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 2Health News:Robotic-assisted prostate cancer surgery drives up costs, UPMC study finds 3Health News:'Obesity genes' may influence food choices, eating patterns 2Health News:British experts update addiction treatment guidelines 2Health News:Phthalates in PVC floors taken up by the body in infants 2
... For International Licensing, LAS VEGAS, July ... http://www.skinvisible.com, , http://www.invisicare.com ), the developers of ... topical skincare products, announces,the successful development of ... ingredient avobenzone (Parsol(R) 1789) with Invisicare. Avobenzone,is ...
... CORAL GABLES, Fla., July 29 Stiefel ... pharmaceutical,company specializing in dermatology, announced today that ... Act of 1976, as,amended ("HSR Act") has ... Inc. ("Barrier Therapeutics") (Nasdaq: BTRX )., ...
... N.C., July 29 DiaLog, Inc., a ... joint agreement with DeliverMed,Holdings, LLC, an Illinois-based, ... the DiaLog System, promotes compliance,and adherence to ... and their,physicians better manage their disease. DeliverMed ...
... that are heavily implicated in human multiple myeloma and other ... and readouts that could help in the tailored treatment of ... antibodies, form a key part of our ,immune response,. To ... B cells, not too many and not too few. This ...
... world-wide who have contracted a highly resistant strain of ... to treat the infection. , Research co-authored by ... in HIV Epidemiology and Clinical Research (NCHECR) shows that ... traditional treatments have had good results from a new ...
... hay fever might enjoy a surprise benefit, according to research ... In a paper presented at an international symposium in Sydney, ... diseases are up to 25 percent less likely to get ... InterLymph Symposium is co-hosted by the Leukaemia Foundation, the Cancer ...
Other Medicine News:Health News:Skinvisible Offers 8 Hour Photostablity for Parsol 1789 2Health News:Skinvisible Offers 8 Hour Photostablity for Parsol 1789 3Health News:Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc. 2Health News:Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc. 3Health News:Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc. 4Health News:DiaLog Signs Agreement with DeliverMed to Improve Diabetic Patient Management 2Health News:How molecules out of balance lead to human multiple myeloma and other cancers 2Health News:New therapy for HIV treatment 2Health News:Hey fever! The surprise benefit of allergies 2
(Date:5/23/2012)... CARLSBAD, Calif., May 23 2012  Isis Pharmaceuticals, ... following webcast:What:Data from KYNAMRO™ presented at EAS 2012When:Friday, ... a.m. PTWhere:www.isispharm.comHow:Live on the Internet.  Simply log onto ... unable to participate during the live event, a ... a limited time at www.isispharm.com . ...
(Date:5/23/2012)... 23, 2012 Reportlinker.com ... research report is available in ... Global Medical Devices Survey ... and Procurement Strategies in the ... http://www.reportlinker.com/p0801518/Global-Medical-Devices-Survey-2012–2013-Market-Trends-Buyer-Spend-and-Procurement-Strategies-in-the-Global-Medical-Devices-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_D ...
(Date:5/23/2012)... 23, 2012 According to ... surveyed reported temperature excursions in 6% or more ... of pharmaceutical products can not only result in ... Cold Chain IQ presents a new report ... clinical and commercial products and leading strategies that ...
Breaking Medicine Technology:Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 2Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 3Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 4Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 5Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 6Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 7Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 8Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 9Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 10Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 11Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 12Global Medical Devices Survey 2012-2013: Market Trends, Buyer Spend and Procurement Strategies in the Global Medical Devices Industry 13New 2012 Cold Chain Report Examines the Extent of Temperature Excursions During the Handling of Temperature-Sensitive Pharmaceutical Shipments 2Watson Confirms AVODART 28R 29 Patent Challenge 18240 1Watson Confirms AVODART 28R 29 Patent Challenge 18240 2One in 12 U S Children May Have Food Allergies 3A Report 83020 1One in 12 U S Children May Have Food Allergies 3A Report 83020 2One in 12 U S Children May Have Food Allergies 3A Report 83020 3Faster Transition From CPR to Defibrillator May Save Lives 83018 1Faster Transition From CPR to Defibrillator May Save Lives 83018 2
... N.J., Jan. 28 Synvista Therapeutics, Inc. (NYSE ... review of its clinical development portfolio and its current ... determined that it is in the best interest of ... value of its diagnostic assets and to terminate all ...
... symbol ,CDXP.OB, LA JOLLA, Calif., Jan. 28 Duska ... it has completed a corporate name change to Cordex ... the Over-the-Counter Bulletin Board will trade the Company,s common ... M.D., Cordex,s Chief Executive Officer commented, "We are pleased ...
Other Medicine Technology:Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update 2Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update 3Duska Therapeutics Completes Corporate Name Change to Cordex Pharma 2Duska Therapeutics Completes Corporate Name Change to Cordex Pharma 3
Implex cemented hip stem....
Stability cemented stem....
Porous foundation 440 series....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: